LASIK microkeratomes, a cost-effective solution

Article

At this year's ESCRS in Paris, Moria showcased its One range of single-use, high precision, handheld surgical instruments, including the One Use-Plus SBK.

At this year's ESCRS in Paris, Moria showcased its One range of single-use, high precision, handheld surgical instruments, including the One Use-Plus SBK. This new generation of LASIK microkeratomes reportedly achieves accuracy and visual results equivalent to femtolasers at a fraction of the cost.

The One Use-Plus system is a linear, automated, microkeratome featuring a nasal hinge and two head sizes (90 and 130) for customizable flap thickness of 100 µm and 130 µm on average, respectively. In addition to this surgeons can benefit from three single use suction rings, -1, 0 and +1, to accommodate for all keratometries. The company claims the instrument can help doctors achieve predictable, thin flaps with planar profiles, resulting in outstanding visual outcomes that are equivalent or better than those achieved with a femtolaser with less discomfort to the patient.

Moria has been working with corneal surgeons in the field of DSAEK on the relatively new technique of Ultra-Thin DSAEK.

For more information on the One range of products visit the company's website at www.moria-surgical.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.